RPL17 and cancer: When co-culturing Gal-9 overexpressing cancer cells with T cells, we observed a significant increase in the percentage of CD8+PD1+, CD8+PD1+Tim3+, and CD8+PD-1+Tim-3+Lag-3+ T cell populations (Figures 4G–L).